Healthcare provider profile · identity verified

Ibrahim Ghobrial

Internal Medicine · MCKEESPORT, PA · NPI 1336102219

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	607	166
Amlodipine Besylate	Amlodipine Besylate	573	170
Metformin Hcl Er	Metformin Hcl	355	108
Losartan Potassium	Losartan Potassium	310	78
Rosuvastatin Calcium	Rosuvastatin Calcium	251	70
Metoprolol Succinate	Metoprolol Succinate	216	54
Gabapentin	Gabapentin	214	38
Omeprazole	Omeprazole	207	54
Levothyroxine Sodium	Levothyroxine Sodium	192	51
Pantoprazole Sodium	Pantoprazole Sodium	183	43
Albuterol Sulfate Hfa	Albuterol Sulfate	174	52
Tamsulosin Hcl	Tamsulosin Hcl	165	47
Fluticasone Propionate	Fluticasone Propionate	164	60
Carvedilol	Carvedilol	160	45
Ozempic	Semaglutide	156	26
Furosemide	Furosemide	155	33
Lisinopril	Lisinopril	154	40
Jardiance	Empagliflozin	135	40
Eliquis	Apixaban	126	29
Metformin Hcl	Metformin Hcl	123	40
Potassium Chloride	Potassium Chloride	117	24
Trazodone Hcl	Trazodone Hcl	117	33
Metoprolol Tartrate	Metoprolol Tartrate	112	19
Hydrochlorothiazide	Hydrochlorothiazide	101	30
Valsartan	Valsartan	96	31
Pravastatin Sodium	Pravastatin Sodium	91	24
Spironolactone	Spironolactone	90	29
Hydralazine Hcl	Hydralazine Hcl	84	23
Triamcinolone Acetonide	Triamcinolone Acetonide	80	32
Rybelsus	Semaglutide	69	17
Prednisone	Prednisone	68	28
Alendronate Sodium	Alendronate Sodium	67	22
Allopurinol	Allopurinol	66	17
Tradjenta	Linagliptin	64	17
Famotidine	Famotidine	63	22
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	59	15
Ibuprofen	Ibuprofen	58	14
Mounjaro	Tirzepatide	58	suppressed
Diclofenac Sodium	Diclofenac Sodium	57	21
Simvastatin	Simvastatin	55	11
Duloxetine Hcl	Duloxetine Hcl	53	20
Clopidogrel	Clopidogrel Bisulfate	49	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	49	16
Baclofen	Baclofen	48	suppressed
Topiramate	Topiramate	48	12
Finasteride	Finasteride	47	15
Fluoxetine Hcl	Fluoxetine Hcl	47	12
Ketoconazole	Ketoconazole	46	19
Celecoxib	Celecoxib	45	16
Mirtazapine	Mirtazapine	45	suppressed
Trulicity	Dulaglutide	43	12
Montelukast Sodium	Montelukast Sodium	42	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	13
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	40	suppressed
Ezetimibe	Ezetimibe	40	11
Valacyclovir	Valacyclovir Hcl	38	suppressed
Ventolin Hfa	Albuterol Sulfate	38	13
Warfarin Sodium	Warfarin Sodium	38	suppressed
Naproxen	Naproxen	37	suppressed
Sertraline Hcl	Sertraline Hcl	37	15
Clonazepam	Clonazepam	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	15
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	suppressed
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Chlorthalidone	Chlorthalidone	32	14
Tizanidine Hcl	Tizanidine Hcl	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	suppressed
Tramadol Hcl	Tramadol Hcl	31	suppressed
Atenolol	Atenolol	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Naltrexone Hcl	Naltrexone Hcl	25	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Linzess	Linaclotide	22	suppressed
Rizatriptan	Rizatriptan Benzoate	22	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Doxepin Hcl	Doxepin Hcl	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	16
Levetiracetam	Levetiracetam	21	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Loperamide	Loperamide Hcl	19	suppressed
Varenicline Tartrate	Varenicline Tartrate	19	14
Bupropion Xl	Bupropion Hcl	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	15	suppressed
Amlodipine-Valsartan-Hctz	Amlodipine/Valsartan/Hcthiazid	14	suppressed
Colchicine	Colchicine	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Azithromycin	Azithromycin	13	suppressed
Clonidine	Clonidine	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Probenecid-Colchicine	Probenecid/Colchicine	13	suppressed
Repaglinide	Repaglinide	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Ultiguard Safepack-Pen Needle	Pen Needle, Diabetic,disp Unit	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error